| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5941305510c5714dfa0a0d94047e1e04 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-627
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-60 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2809
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2878
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2827 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate |
2020-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c328ed2910314c23e08ba577c3eccb1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be3bda28524adc4067107e420885bf7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87b0f45a10068e709369d708864e939d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc051ef0590ad9c85cfc4041231536fe |
| publicationDate |
2021-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20210151204-A |
| titleOfInvention |
Multi-specific antigen binding protein complexes capable of being activated |
| abstract |
The present disclosure provides multiple specific antigen binding protein complexes. In some embodiments, the multispecific antigen binding protein complex consists of either two or three polypeptide chains, wherein the chains assemble with one another to form two different Fab regions, each capable of binding two different epitopes. and has a relatively simple structure compared to certain other multispecific antibodies as it forms a heterodimeric complex comprising an Fc region capable of exhibiting Fc effector functions. In one embodiment, the multispecific antigen binding protein complex can be activated as one of the polypeptide chains that make up the protein complex with a cleavable linker. |
| priorityDate |
2019-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |